im-1617
im-1617: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Immunome Inc. (IMNM) | Phase 1 |
Get deeper analysis on im-1617
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis